Dr. Peter Fisher: An Enduring Force for Homeopathy.

@article{Mathie2018DrPF,
  title={Dr. Peter Fisher: An Enduring Force for Homeopathy.},
  author={Robert T. Mathie},
  journal={Homeopathy : the journal of the Faculty of Homeopathy},
  year={2018},
  volume={107 4},
  pages={
          223-224
        }
}
  • R. Mathie
  • Published 1 November 2018
  • Medicine
  • Homeopathy : the journal of the Faculty of Homeopathy
The world of homeopathy continues to mourn Peter Fisher’s sudden death in a terrible road accident in August. Collectively and individually, we suffer the pain of losing homeopathy’s most prominent opinion leader, the longest-standing Editor-in-Chief of this journal, and this year’s President of the Faculty of Homeopathy. Medicine, more generally, has lost one of its most passionate and successful advocates for the integration of complementary and conventional treatments in individuals with… 

References

SHOWING 1-10 OF 13 REFERENCES

Peter Fisher: homeopathic physician to the Queen

Peter Fisher was probably the nearest anyone will ever get to being homeopathic royalty: homeopathic physician to the Queen, president of the Faculty of Homeopathy, and chair of the World Health

Plausibility and evidence: the case of homeopathy

It is shown that interpretations of the same set of evidence—for homeopathy and for conventional medicine—can diverge, and it is demonstrated that plausibility bias impedes assessment of the clinical evidence.

Homeopathy and antimicrobial resistance.

  • P. Fisher
  • Medicine
    Homeopathy : the journal of the Faculty of Homeopathy
  • 2014

Homeopathy for dementia.

Evaluating the effectiveness and safety profile of homeopathically prepared medications used in treating dementia, as established by randomized controlled trials found no studies that fulfilled the criteria for inclusion and no data to present.

Effect of homeopathic treatment on fibrositis (primary fibromyalgia)

In conclusion, interstitial laser hyperthermia is feasible and seems to be safe and the combination of technologies may be valuable for treating otherwise untreatable tumours in a range of solid organs and for the primary treatment of small neoplasms.

A randomized controlled trial of homeopathy in rheumatoid arthritis.

No evidence that active homeopathy improves the symptoms of RA, over 3 months, in patients attending a routine clinic who are stabilized on NSAIDs or DMARDs is found.

Homeopathic Oscillococcinum(®) for preventing and treating influenza and influenza-like illness.

The findings do not rule out the possibility that Oscillococcinum(®) could have a clinically useful treatment effect but, given the low quality of the eligible studies, the evidence is not compelling.

Method for appraising model validity of randomised controlled trials of homeopathic treatment: multi-rater concordance study

MVHT is defined as the extent to which a homeopathic intervention and the main measure of its outcome, as implemented in a randomised controlled trial (RCT), reflect 'state-of-the-art' homeopathic practice.

NHS patients' perspective on complementary medicine: a survey.

Homeopathic medicines for adverse effects of cancer treatments.

Preliminary data is found in support of the efficacy of topical calendula for prophylaxis of acute dermatitis during radiotherapy and Traumeel S mouthwash in the treatment of chemotherapy-induced stomatitis in patients with cancer.